Literature DB >> 15723170

The N-terminus of HIV-1 Tat protein is essential for Tat-TAR RNA interaction.

O Chaloin1, J-C Peter, J-P Briand, B Masquida, C Desgranges, S Muller, J Hoebeke.   

Abstract

The human HIV transactivator protein Tat is essential for efficient viral transcription that occurs by a complex mechanism involving interaction of Tat with the TAR RNA element. This interaction appears to require the mediation of a cellular protein, cyclin T1. However, the possibility that Tat and TAR associate in a binary Tat-TAR complex has been little investigated. Using a chemically synthesized active Tat protein, the kinetic and equilibrium parameters of its interaction with TAR were determined by surface plasmon resonance technology. Independently of partner and method of immobilization onto the sensor chip, the association (k(a) = 5-9 x 10(5) M(-1) s(-1)) and dissociation rate constants (k(d) = 1.7-4.3 x 10(-3) s(-1)) yielded similar equilibrium dissociation constants (K(d) = 2-8 nM). A truncated peptide encompassing residues 30-86 of Tat did not bind to TAR at all. We conclude that Tat can form a high-affinity complex with TAR in the absence of cyclin T1 and that the N-terminal domain of Tat is essential for this interaction, suggesting a conformational link between this domain and the basic domain of Tat. These results are important in our quest for developing therapeutic compounds that impair viral replication.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15723170     DOI: 10.1007/s00018-004-4477-1

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  9 in total

1.  Guidelines on myocardial revascularization.

Authors:  William Wijns; Philippe Kolh; Nicolas Danchin; Carlo Di Mario; Volkmar Falk; Thierry Folliguet; Scot Garg; Kurt Huber; Stefan James; Juhani Knuuti; Jose Lopez-Sendon; Jean Marco; Lorenzo Menicanti; Miodrag Ostojic; Massimo F Piepoli; Charles Pirlet; Jose L Pomar; Nicolaus Reifart; Flavio L Ribichini; Martin J Schalij; Paul Sergeant; Patrick W Serruys; Sigmund Silber; Miguel Sousa Uva; David Taggart
Journal:  Eur Heart J       Date:  2010-08-29       Impact factor: 29.983

2.  Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial.

Authors:  Friedrich W Mohr; Marie-Claude Morice; A Pieter Kappetein; Ted E Feldman; Elisabeth Ståhle; Antonio Colombo; Michael J Mack; David R Holmes; Marie-angèle Morel; Nic Van Dyck; Vicki M Houle; Keith D Dawkins; Patrick W Serruys
Journal:  Lancet       Date:  2013-02-23       Impact factor: 79.321

3.  2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

Authors:  Stephan Windecker; Philippe Kolh; Fernando Alfonso; Jean-Philippe Collet; Jochen Cremer; Volkmar Falk; Gerasimos Filippatos; Christian Hamm; Stuart J Head; Peter Jüni; A Pieter Kappetein; Adnan Kastrati; Juhani Knuuti; Ulf Landmesser; Günther Laufer; Franz-Josef Neumann; Dimitrios J Richter; Patrick Schauerte; Miguel Sousa Uva; Giulio G Stefanini; David Paul Taggart; Lucia Torracca; Marco Valgimigli; William Wijns; Adam Witkowski
Journal:  Eur Heart J       Date:  2014-08-29       Impact factor: 29.983

4.  Paclitaxel-Eluting versus Everolimus-Eluting Coronary Stents in Diabetes.

Authors:  Upendra Kaul; Sripal Bangalore; Ashok Seth; Priyadarshini Arambam; Rajpal K Abhaichand; Rajpal K Abhaychand; Tejas M Patel; Darshan Banker; Atul Abhyankar; Ajit S Mullasari; Sanjay Shah; Rajneesh Jain; Premchand R Kumar; C G Bahuleyan
Journal:  N Engl J Med       Date:  2015-10-14       Impact factor: 91.245

5.  Fractional flow reserve versus angiography for guiding percutaneous coronary intervention.

Authors:  Pim A L Tonino; Bernard De Bruyne; Nico H J Pijls; Uwe Siebert; Fumiaki Ikeno; Marcel van' t Veer; Volker Klauss; Ganesh Manoharan; Thomas Engstrøm; Keith G Oldroyd; Peter N Ver Lee; Philip A MacCarthy; William F Fearon
Journal:  N Engl J Med       Date:  2009-01-15       Impact factor: 91.245

6.  Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.

Authors:  Patrick W Serruys; Marie-Claude Morice; A Pieter Kappetein; Antonio Colombo; David R Holmes; Michael J Mack; Elisabeth Ståhle; Ted E Feldman; Marcel van den Brand; Eric J Bass; Nic Van Dyck; Katrin Leadley; Keith D Dawkins; Friedrich W Mohr
Journal:  N Engl J Med       Date:  2009-02-18       Impact factor: 91.245

7.  Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease.

Authors:  Bernard De Bruyne; Nico H J Pijls; Bindu Kalesan; Emanuele Barbato; Pim A L Tonino; Zsolt Piroth; Nikola Jagic; Sven Möbius-Winkler; Sven Mobius-Winckler; Gilles Rioufol; Nils Witt; Petr Kala; Philip MacCarthy; Thomas Engström; Keith G Oldroyd; Kreton Mavromatis; Ganesh Manoharan; Peter Verlee; Ole Frobert; Nick Curzen; Jane B Johnson; Peter Jüni; William F Fearon
Journal:  N Engl J Med       Date:  2012-08-27       Impact factor: 91.245

8.  Strategies for multivessel revascularization in patients with diabetes.

Authors:  Michael E Farkouh; Michael Domanski; Lynn A Sleeper; Flora S Siami; George Dangas; Michael Mack; May Yang; David J Cohen; Yves Rosenberg; Scott D Solomon; Akshay S Desai; Bernard J Gersh; Elizabeth A Magnuson; Alexandra Lansky; Robin Boineau; Jesse Weinberger; Krishnan Ramanathan; J Eduardo Sousa; Jamie Rankin; Balram Bhargava; John Buse; Whady Hueb; Craig R Smith; Victoria Muratov; Sameer Bansilal; Spencer King; Michel Bertrand; Valentin Fuster
Journal:  N Engl J Med       Date:  2012-11-04       Impact factor: 91.245

9.  2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).

Authors:  Marco Roffi; Carlo Patrono; Jean-Philippe Collet; Christian Mueller; Marco Valgimigli; Felicita Andreotti; Jeroen J Bax; Michael A Borger; Carlos Brotons; Derek P Chew; Baris Gencer; Gerd Hasenfuss; Keld Kjeldsen; Patrizio Lancellotti; Ulf Landmesser; Julinda Mehilli; Debabrata Mukherjee; Robert F Storey; Stephan Windecker
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

  9 in total
  8 in total

1.  A modified fluorescent intercalator displacement assay for RNA ligand discovery.

Authors:  Papa Nii Asare-Okai; Christine S Chow
Journal:  Anal Biochem       Date:  2010-09-21       Impact factor: 3.365

Review 2.  Defining the molecular mechanisms of HIV-1 Tat secretion: PtdIns(4,5)P2 at the epicenter.

Authors:  Anthony R Mele; Jamie Marino; Kenneth Chen; Vanessa Pirrone; Chris Janetopoulos; Brian Wigdahl; Zachary Klase; Michael R Nonnemacher
Journal:  Traffic       Date:  2018-04-30       Impact factor: 6.215

3.  Induction of monocyte chemoattractant protein-1 (MCP-1/CCL2) gene expression by human immunodeficiency virus-1 Tat in human astrocytes is CDK9 dependent.

Authors:  Abdelkader Khiati; Olivier Chaloin; Sylviane Muller; Marc Tardieu; Philippe Horellou
Journal:  J Neurovirol       Date:  2010-03       Impact factor: 2.643

4.  HIV-1 Tat protein directly induces mitochondrial membrane permeabilization and inactivates cytochrome c oxidase.

Authors:  H Lecoeur; A Borgne-Sanchez; O Chaloin; R El-Khoury; M Brabant; A Langonné; M Porceddu; J-J Brière; N Buron; D Rebouillat; C Péchoux; A Deniaud; C Brenner; J-P Briand; S Muller; P Rustin; E Jacotot
Journal:  Cell Death Dis       Date:  2012-03-15       Impact factor: 8.469

5.  The HIV-1 transcriptional activator Tat has potent nucleic acid chaperoning activities in vitro.

Authors:  Monika Kuciak; Caroline Gabus; Roland Ivanyi-Nagy; Katharina Semrad; Roman Storchak; Olivier Chaloin; Sylviane Muller; Yves Mély; Jean-Luc Darlix
Journal:  Nucleic Acids Res       Date:  2008-04-28       Impact factor: 16.971

6.  In silico Analyses of Subtype Specific HIV-1 Tat-TAR RNA Interaction Reveals the Structural Determinants for Viral Activity.

Authors:  Larance Ronsard; Tripti Rai; Devesh Rai; Vishnampettai G Ramachandran; Akhil C Banerjea
Journal:  Front Microbiol       Date:  2017-08-08       Impact factor: 5.640

7.  Modulation of microtubule assembly by the HIV-1 Tat protein is strongly dependent on zinc binding to Tat.

Authors:  Caroline Egelé; Pascale Barbier; Pascal Didier; Etienne Piémont; Diane Allegro; Olivier Chaloin; Sylviane Muller; Vincent Peyrot; Yves Mély
Journal:  Retrovirology       Date:  2008-07-09       Impact factor: 4.602

8.  Studies on human eRF3-PABP interaction reveal the influence of eRF3a N-terminal glycin repeat on eRF3-PABP binding affinity and the lower affinity of eRF3a 12-GGC allele involved in cancer susceptibility.

Authors:  Soumaya Jerbi; Béatrice Jolles; Tahar Bouceba; Olivier Jean-Jean
Journal:  RNA Biol       Date:  2016-01-28       Impact factor: 4.652

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.